{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:23:27Z","timestamp":1793391807674,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.berh.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T08:49:19Z","timestamp":1542358159000},"page":"241-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis"],"prefix":"10.1016","volume":"32","author":[{"given":"Clementina","family":"L\u00f3pez-Medina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Molt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2018.10.006_bib1","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1038\/nrdp.2015.13","article-title":"Axial spondyloarthritis","volume":"1","author":"Sieper","year":"2015","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2018.10.006_bib3","first-page":"36","volume":"vol. II","author":"Kellgren","year":"1963"},{"key":"10.1016\/j.berh.2018.10.006_bib4","series-title":"Population studies of rheumatic diseases","first-page":"456","author":"Bennett","year":"1968"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00002281-200007000-00002","article-title":"Scientific contributors of ankylosing spondylitis patients advocacy groups","volume":"12","author":"Feldtkeller","year":"2000","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib7","first-page":"85","article-title":"Criteria of the classification of spondyloarthropathies","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Ost\u00e9o Articul"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opini\u00f3n including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2018.10.006_bib11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/annrheumdis-2016-209785","article-title":"Disease trajectories in early axial spondyloarthritis: results from the DESIR cohort","volume":"76","author":"Molt\u00f3","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/annrheumdis-2013-204262","article-title":"Evaluation of the validity of the different arms of the ASAS set of criteria for axial spondyloarthritis and description of the different imaging abnormalities suggestive of spondyloarthritis: data from the DESIR cohort","volume":"74","author":"Molt\u00f3","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","article-title":"Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis","volume":"76","author":"Sepriano","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/annrheumdis-2015-208730","article-title":"Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis","volume":"75","author":"Sepriano","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","article-title":"Epidemiology of spondyloarthritis","volume":"38","author":"Stolwijk","year":"2012","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ajpa.1330750304","article-title":"Antigen and haplotype frequencies at three human leucocytes antigen loci (HLA-A, -B, -C) in the Pawaia of Papua New Guinea","volume":"75","author":"Bhatia","year":"1988","journal-title":"Am J Phys Anthropol"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib18","first-page":"572","article-title":"HL-A 27 and ankylosing spondylitis in B.C. Indians","volume":"11","author":"Gofton","year":"1984","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib19","first-page":"554","article-title":"Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society","volume":"28","author":"Hukuda","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2018.10.006_bib20","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3899\/jrheum.120403","article-title":"HLA-B27 prevalence in Arab populations and among patients with ankylosing spondylitis","volume":"39","author":"Mustafa","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","article-title":"Global prevalence of ankylosing spondylitis","volume":"53","author":"Dean","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.berh.2018.10.006_bib22","first-page":"1591","article-title":"The prevalence of ankylosing spondylitis among Norwegian Samis (Lapps)","volume":"19","author":"Johnsen","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G","article-title":"Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors","volume":"41","author":"Braun","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2018.10.006_bib24","first-page":"1589","article-title":"Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study","volume":"30","author":"Andrianakos","year":"2003","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2018.10.006_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/art.1780220408","article-title":"Epidemiology of ankylosing spondylitis in Rochester, Minnesota, 1935-1973","volume":"22","author":"Carter","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.10.006_bib26","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/art.1780351211","article-title":"Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing?","volume":"35","author":"Carbone","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib27","first-page":"496","article-title":"Incidence and prevalence of ankylosing spondylitis in Finland","volume":"24","author":"Kaipiainen-Seppanen","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/art.21577","article-title":"Incidence and prevalence of ankylosing spondylitis in Northern Norway","volume":"53","author":"Bakland","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/art.33503","article-title":"The prevalence of HLA-B27 in the US: data from the US national health and Nutrition examination survey, 2009","volume":"64","author":"Reveille","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2018.10.006_bib30","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s10067-017-3767-6","article-title":"Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups","volume":"36","author":"Jamalyaria","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2018.10.006_bib31","first-page":"2286","article-title":"A\u00a0new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garret","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jbspin.2015.02.006","article-title":"Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: the DESIR cohort","volume":"82","author":"Dougados","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.berh.2018.10.006_bib33","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1136\/annrheumdis-2014-205178","article-title":"Higher disease activity leads to more structural damage in the spine in akylosing spondylitis: 12-year longitudinal data from the OASIS cohort","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib34","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/ard.61.6.534","article-title":"Histological assessment of the early enthesitis lesion in spondyloarthropathy","volume":"61","author":"McGonagle","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2018.10.006_bib35","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-yt+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.berh.2018.10.006_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.0105-2896.2009.00852.x","article-title":"Genetics and genomics of ankylosing spondylitis","volume":"233","author":"Thomas","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1016\/j.berh.2018.10.006_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/242121a0","article-title":"Human lymphocyte antigen association with ankylosing spondylitis","volume":"242","author":"Caffrey","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.berh.2018.10.006_bib38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM197304052881403","article-title":"High association of an HLA-antigen, W27, with ankylosing spondylitis","volume":"288","author":"Schlosstein","year":"1973","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0092-8674(90)90512-D","article-title":"Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27 associated human disorders","volume":"63","author":"Hammer","year":"1990","journal-title":"Cell"},{"issue":"8872","key":"10.1016\/j.berh.2018.10.006_bib40","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0140-6736(93)91760-J","article-title":"HLA-27-restricted CD8 T cells derived from synovial fluids on patients with reactive arthritis and ankylosing spondylitis","volume":"342","author":"Hermann","year":"1993","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.berh.2018.10.006_bib41","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1002\/art.24599","article-title":"Spondyloarthritis in HLA-B27\/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8","volume":"60","author":"Taurog","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2018.10.006_bib42","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/art.10605","article-title":"Cell-surface expression and immune receptor recognition of HLA-B27 homodimers","volume":"46","author":"Kollnberger","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2018.10.006_bib43","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1089\/ars.2009.2686","article-title":"The unfolded protein response in health and disease","volume":"11","author":"Austin","year":"2009","journal-title":"Antioxidants Redox Signal"},{"issue":"9","key":"10.1016\/j.berh.2018.10.006_bib44","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment IL-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib45","first-page":"394","article-title":"Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease","volume":"18","author":"Mielants","year":"1991","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2018.10.006_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crhon's disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","article-title":"Genetics of ankylosing spondylitis \u2013 insights into pathogenesis","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.berh.2018.10.006_bib48","first-page":"2155","article-title":"An enthesitis based model for the pathogenesis of spondyloarthritis. Additive effects of microbial adjuvant and biomechanical factors at diseases sites","volume":"28","author":"McGonagle","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib51","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/ard.2008.102046","article-title":"Blockade of dickkopf (DKK)-1 induces fusion of sacroiliac joints","volume":"69","author":"Uderhardt","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/art.23260","article-title":"Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes","volume":"58","author":"Sieper","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2018.10.006_bib53","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/art.39666","article-title":"Rate and predisposing factors for the sacroiliac joint radiographic progression after two-year follow-up in recent-onset spondyloarthritis","volume":"68","author":"Dougados","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/ard.2004.020503","article-title":"Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system","volume":"64","author":"Creemers","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib55","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondyloarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.10.006_bib56","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"Van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.10.006_bib57","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etarnecept","volume":"58","author":"Van der Heijde","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2018.10.006_bib58","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"Van der Heijde","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib59","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/annrheumdis-2017-211544","article-title":"TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort","volume":"77","author":"Molnar","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/annrheumdis-2016-209730","article-title":"Effect of secukinumab on clinical and radiographic outcomes in ankylosing spondylitis: 2-year results from the randomised phase III MEASURE 1 study","volume":"76","author":"Braun","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2018.10.006_bib61","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/annrheumdis-2012-203148","article-title":"Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort (GESPIC)","volume":"72","author":"Poddubnyy","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000153","article-title":"Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis","volume":"1","author":"Ramiro","year":"2015","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib63","first-page":"25","article-title":"Extra-articular manifestations and complications of ankylosing spondylitis","volume":"1","author":"Gratacos","year":"2005","journal-title":"Reumatol Cl\u00ednica"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib64","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/annrheumdis-2016-209233","article-title":"Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative","volume":"75","author":"Baillet","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.10.006_bib65","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fmed.2018.00062","article-title":"Comorbidities in spondyloarthritis","volume":"5","author":"Molt\u00f3","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib66","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2010.137216","article-title":"EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"70","author":"van Assen","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib68","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","article-title":"Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study","volume":"75","author":"Molt\u00f3","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2018.10.006_bib69","article-title":"Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: an ancillary study of the ASAS-COMOSPA project","author":"L\u00f3pez-Medina","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib70","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/ar3833","article-title":"Osteoporosis in ankylosing spondylitis \u2013 prevalence, risk factors and methods of assessment","volume":"14","author":"Klingberg","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.berh.2018.10.006_bib71","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.bone.2008.12.028","article-title":"Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis","volume":"44","author":"Ghozlani","year":"2009","journal-title":"Bone"},{"issue":"12","key":"10.1016\/j.berh.2018.10.006_bib72","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1136\/annrheumdis-2012-201845","article-title":"Bone oedema on MRI is highly associated with low bone mineral density in patients with early inflammatory back pain: results from the DESIR cohort","volume":"72","author":"Briot","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib73","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/rheumatology\/kev332","article-title":"Bone loss in patients with early inflammatory back pain suggestive of spondyloarthritis: results from the prospective DESIR cohort","volume":"55","author":"Briot","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2018.10.006_bib74","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/annrheumdis-2016-209315","article-title":"Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?","volume":"76","author":"Eriksson","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 55","key":"10.1016\/j.berh.2018.10.006_bib75","article-title":"Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis","volume":"27","author":"McCarey","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib76","first-page":"612","article-title":"Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Papagoras","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2018.10.006_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/acr.20408","article-title":"Population-Based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis","volume":"63","author":"Bremander","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.berh.2018.10.006_bib78","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"Szabo","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2018.10.006_bib79","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/ard.2009.110593","article-title":"Ankylosing spondylitis; a risk factor for myocardial infraction?","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib80","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","article-title":"Spondyloarthropathies: an independent cardiovascular risk factor?","volume":"77","author":"Mathieu","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib81","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib82","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jbspin.2013.03.019","article-title":"Cardiovascular risk profile in patients with spondyloarthritis","volume":"81","author":"Papagoras","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.berh.2018.10.006_bib83","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","article-title":"Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study","volume":"163","author":"Haroon","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.berh.2018.10.006_bib84","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1136\/ard.2011.151191","article-title":"Increased mortality in ankylosing spondylitis is related to disease activity","volume":"70","author":"Bakland","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2018.10.006_bib85","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/acr.22926","article-title":"Risk of cardiovascular morbidity in patients with psoriatic arthritis: a meta-analysis of observational studies","volume":"69","author":"Polachek","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421830069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169421830069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:18:23Z","timestamp":1761499103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169421830069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S152169421830069X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2018.10.006","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}